Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Platelet glycoprotein VI promotes metastasis through interaction with cancer cell–derived galectin-3

Elmina Mammadova-Bach, Jesus Gil-Pulido, Edita Sarukhanyan, Philipp Burkard, Sergey Shityakov, Charlotte Schonhart, David Stegner, Katharina Remer, Paquita Nurden, Alan T. Nurden, Thomas Dandekar, Laszlo Nehez, Magdolna Dank, Attila Braun, Diego Mezzano, Scott I. Abrams, Bernhard Nieswandt

Blood (2020) 135 (14): 1146–1160.

https://doi.org/10.1182/blood.2019002649

Published: 2020

Includes: Supplemental data

Journal Articles

Von Willebrand Factor in Angiogenesis and Angiodysplasia

Anna M Randi, MD PhD

Blood (2018) 132 (Supplement 1): SCI-43.

https://doi.org/10.1182/blood-2018-99-109556

Published: 2018

Journal Articles

Bone Marrow Stromal Cells Mediate Adhesion Based Drug Resistance in Acute Myeloid Leukaemia through Reciprocal Feedback of the β-Catenin/CD44 Signalling Axis

Lihui Zhuang, PhD MSc, BSc, Richard Darley, PhD, Oliver G. Ottmann, MD, Joanna Zabkiewicz, PhD, Caroline Alvares, MBBS, PhD

Blood (2018) 132 (Supplement 1): 2776.

https://doi.org/10.1182/blood-2018-99-113811

Published: 2018

Journal Articles

A Novel Glycomimetic Compound (GMI-1757) with Dual Functional Antagonism to E-Selectin and Galectin-3 Demonstrates Inhibition of Thrombus Formation in an Inferior Vena Cava Model

John Peterson, PhD, Yusuf Vohra, PhD, Daniel Durant Myers, DVM, MPH, Silvia Locatelli-Hoops, PhD, Ji-Won Lee, PhD, Lingquan Deng, PhD, Theodore AG Smith, PhD, William E Fogler, PhD, John L Magnani, PhD

Blood (2018) 132 (Supplement 1): 2211.

https://doi.org/10.1182/blood-2018-99-118122

Published: 2018

Journal Articles

von Willebrand factor regulation of blood vessel formation

Anna M. Randi, Koval E. Smith, Giancarlo Castaman

Blood (2018) 132 (2): 132–140.

https://doi.org/10.1182/blood-2018-01-769018

Published: 2018

Journal Articles

Galectin 3 Protein Network Analysis By Reverse Protein Arrays Demonstrates Regulation of MCL-1, PKC Delta and CD74 Associated with Poor Survival in Patients with AML

Peter P. Ruvolo, PhD, Chenyue Hu, Yihua Qiu, Vivian Ruvolo, PhD, Kevin R Coombes, Amina Qutub, Michael Andreeff, MD PhD, Steven Kornblau, MD

Blood (2017) 130 (Supplement 1): 1395.

https://doi.org/10.1182/blood.V130.Suppl_1.1395.1395

Published: 2017

Journal Articles

Alterations in Cytokine Profiles Have Potential Uses As Biomarkers for Pediatric Venous Thromboembolism

Robert L Meller, III, BS, Christine Brzezinski, MS, Christopher J. Ng, MD, Allaura Cox, BS, Julie Smith, BS, Jorge Di Paola, MD, Marilyn J Manco-Johnson, MD, Brian R. Branchford, MD

Blood (2017) 130 (Supplement 1): 1078.

https://doi.org/10.1182/blood.V130.Suppl_1.1078.1078

Published: 2017

Journal Articles

MAF Induces Inflammatory Mediators Involved in the Pathogenesis of Primary Myelofibrosis

Samantha Ruberti, BSc, Elisa Bianchi, PhD, Tiziana Fanelli, MSc, Sebastiano Rontauroli, BSc, Valentina Pennucci, PhD, Giuditta Corbizzi Fattori, BSc, Carmela Mannarelli, MSc, PhD, Ruggiero Norfo, PhD, Chiara Rossi, BSc, Roberta Zini, PhD, Simona Salati, PhD, Zelia Prudente, PhD, Enrico Tagliafico, MDPhD, Paola Guglielmelli, MD PhD, Alessandro M. Vannucchi, MD, Rossella Manfredini, PhDBSc

Blood (2016) 128 (22): 3132.

https://doi.org/10.1182/blood.V128.22.3132.3132

Published: 2016

Journal Articles

Galectin-3 Is a Mediator of Pulmonary Fibrosis in Sickle Cell Disease: Novel Roles for Hemolysis and Acute Chest Syndrome

Itia Lee, BS, Ciprian Anea, MD, Sanjiv Kumar, PhD, Greer Falls, MD, Aluya Oseghale, BSc, MSc, Julia Brittain, PhD

Blood (2016) 128 (22): 2480.

https://doi.org/10.1182/blood.V128.22.2480.2480

Published: 2016

Journal Articles

Bone Marrow Macrophage Galectin-3 Regulates Platelet Production through Recognition of O-Glycans on Megakaryocytes

Melissa M Lee-Sundlov, PhD, Renata Grozovsky, PhD, Silvia Giannini, PhD, Martina McGrath, MD, Haley E Ramsey, PhD MSc, Martha Sola-Visner, MD, Karin M. Hoffmeister, MD

Blood (2016) 128 (22): 409.

https://doi.org/10.1182/blood.V128.22.409.409

Published: 2016

Journal Articles

A Genomic Predictive Signature for Rigosertib in Lower Risk MDS Derived By Integrating Clinical Response, Mechanism of Action Data and Simulation

Steven M. Fruchtman, MD, Abdullah Mahmood Ali, PhD, Michael E. Petrone, MD MPH, Patrick Simon Zbyszewski, MBA, Benjamin Hoffman, PhD, Shireen Vali, PhD, Neeraj Kumar Singh, Shahabuddin Usmani, Himanshu Grover, Taher Abbasi, Azra Raza, MD

Blood (2016) 128 (22): 5535.

https://doi.org/10.1182/blood.V128.22.5535.5535

Published: 2016

Journal Articles

Efficient Delivery of Antiapoptotic Signals from Marrow Stromal Cells to Acute Lymphoblastic Leukemia Cells Is Associated with Differential Expression of Genes Related to the Membrane and to Regulation of Apoptosis and Is Dependent in Part on Gap Junction Function

Craig A. Mullen, MD PhD, Sana Usmani, DO, Leti Nunez, BS, Olena Tkachenko, MD

Blood (2016) 128 (22): 5066.

https://doi.org/10.1182/blood.V128.22.5066.5066

Published: 2016

Journal Articles

Galectin-3 and Myocardial Fibrosis By Cardiac Magnetic Resonance in Thalassaemia Major

Paolo Ricchi, MD, Antonella Meloni, Tiziana Di Matola, Anna Spasiano, Aldo Filosa, MD, Silvia Costantini, Luigi Atripaldi, Salvatore Esposito, Patrizia Cinque, Lucia De Franceschi, MD, Alessia Pepe

Blood (2016) 128 (22): 4832.

https://doi.org/10.1182/blood.V128.22.4832.4832

Published: 2016

Journal Articles

Rapamycin Is Highly Effective in a Mouse Model of Immune-Mediated Bone Marrow Failure By Mechanisms Distinct from Cyclosporine

Xingmin Feng, PhD, Zenghua Lin, MD PhD, Marie Desierto, Keyvan Keyvanfar, BS, Daniela Malide, PhD, Jichun Chen, PhD, Neal S. Young, MD

Blood (2015) 126 (23): 1202.

https://doi.org/10.1182/blood.V126.23.1202.1202

Published: 2015

Journal Articles

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

Peter Ruvolo, PhD, Yihua Qiu, MD, Vivian Ruvolo, MS, Rui-Yu Wang, MD PhD, Zhihong Zeng, MD, Jared Burks, PhD, Rongqing Pan, MS, Numsen Hail, Jr., PhD, Teresa McQueen, Suk-Young Yoo, Steven M. Kornblau, MD, Michael Andreeff, MD PhD

Blood (2015) 126 (23): 1198.

https://doi.org/10.1182/blood.V126.23.1198.1198

Published: 2015

Journal Articles

Acute Myelogenous Leukemia (AML) Mesenchymal Stromal Cell (MSC) Have Distinct Protein Expression Patterns Compared to Normal MSC

Steven M. Kornblau, MD, Peter Ruvolo, PhD, Rui-Yu Wang, MD PhD, Vivian Ruvolo, MS, Yihua Qiu, MD, Venkata Lokesh Battula, PhD, Zhihong Zeng, MD, Teresa McQueen, Suk-Young Yoo, Marina Konopleva, MD PhD, Michael Andreeff, MD, PhD

Blood (2015) 126 (23): 3813.

https://doi.org/10.1182/blood.V126.23.3813.3813

Published: 2015

Journal Articles

Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL)

Somayeh Samadzadeh Tarighat, PhD, Fei Fei, Khuchtumur Bum-Erdene, Helen Blanchard, John Groffen, Nora Heisterkamp, PhD

Blood (2015) 126 (23): 2047.

https://doi.org/10.1182/blood.V126.23.2047.2047

Published: 2015

Journal Articles

The role of galectin-3 and galectin-3–binding protein in venous thrombosis

Elise P. DeRoo, Shirley K. Wrobleski, Evelyn M. Shea, Ramsey K. Al-Khalil, Angela E. Hawley, Peter K. Henke, Daniel D. Myers, Jr, Thomas W. Wakefield, Jose A. Diaz

Blood (2015) 125 (11): 1813–1821.

https://doi.org/10.1182/blood-2014-04-569939

Published: 2015

Includes: Supplemental data

Journal Articles

Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)

Sarah Krause, Christian Pfeiffer, Susanne Strube, Ameera Alsadeq, Henning Fedders, Christian Vokuhl, Sonja Loges, Jonas Waizenegger, Isabel Ben-Batalla, Gunnar Cario, Anja Möricke, Martin Stanulla, Martin Schrappe, Denis M. Schewe

Blood (2015) 125 (5): 820–830.

https://doi.org/10.1182/blood-2014-06-583062

Published: 2015

Includes: Supplemental data

Journal Articles

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Richard E. Davis, MD, Vivian R Ruvolo, MA, Zhiqiang Wang, Wencai Ma, PhD, Wendy D. Schober, MLT (ASCP), James Rolke, George Tidmarsh, MD PhD, Michael Andreeff, MD PhD, Peter P. Ruvolo, PhD

Blood (2014) 124 (21): 904.

https://doi.org/10.1182/blood.V124.21.904.904

Published: 2014

NARROW

Platelet glycoprotein VI promotes metastasis through interaction with cancer cell–derived galectin-3

Von Willebrand Factor in Angiogenesis and Angiodysplasia

Bone Marrow Stromal Cells Mediate Adhesion Based Drug Resistance in Acute Myeloid Leukaemia through Reciprocal Feedback of the β-Catenin/CD44 Signalling Axis

A Novel Glycomimetic Compound (GMI-1757) with Dual Functional Antagonism to E-Selectin and Galectin-3 Demonstrates Inhibition of Thrombus Formation in an Inferior Vena Cava Model

von Willebrand factor regulation of blood vessel formation

Galectin 3 Protein Network Analysis By Reverse Protein Arrays Demonstrates Regulation of MCL-1, PKC Delta and CD74 Associated with Poor Survival in Patients with AML

Alterations in Cytokine Profiles Have Potential Uses As Biomarkers for Pediatric Venous Thromboembolism

MAF Induces Inflammatory Mediators Involved in the Pathogenesis of Primary Myelofibrosis

Galectin-3 Is a Mediator of Pulmonary Fibrosis in Sickle Cell Disease: Novel Roles for Hemolysis and Acute Chest Syndrome

Bone Marrow Macrophage Galectin-3 Regulates Platelet Production through Recognition of O-Glycans on Megakaryocytes

A Genomic Predictive Signature for Rigosertib in Lower Risk MDS Derived By Integrating Clinical Response, Mechanism of Action Data and Simulation

Efficient Delivery of Antiapoptotic Signals from Marrow Stromal Cells to Acute Lymphoblastic Leukemia Cells Is Associated with Differential Expression of Genes Related to the Membrane and to Regulation of Apoptosis and Is Dependent in Part on Gap Junction Function

Galectin-3 and Myocardial Fibrosis By Cardiac Magnetic Resonance in Thalassaemia Major

Rapamycin Is Highly Effective in a Mouse Model of Immune-Mediated Bone Marrow Failure By Mechanisms Distinct from Cyclosporine

Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment

Acute Myelogenous Leukemia (AML) Mesenchymal Stromal Cell (MSC) Have Distinct Protein Expression Patterns Compared to Normal MSC

Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL)

The role of galectin-3 and galectin-3–binding protein in venous thrombosis

Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only